Detalhe da pesquisa
1.
Ten years follow up of first degree relatives of type 1 diabetes patients: presence of autoimmune biomarkers and the progression to diabetes in a retrospective cohort.
Arch Endocrinol Metab
; 65(4): 436-442, 2021 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34283897
2.
CA19-9 as a Predictor of Worse Clinical Outcome in Medullary Thyroid Carcinoma.
Eur Thyroid J
; 8(4): 186-191, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31602360
3.
Somatostatin receptor subtype 1 might be a predictor of better response to therapy in medullary thyroid carcinoma.
Endocrine
; 58(3): 474-480, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28948577
4.
Ten years follow up of first degree relatives of type 1 diabetes patients: presence of autoimmune biomarkers and the progression to diabetes in a retrospective cohort
Arch. endocrinol. metab. (Online)
; 65(4): 436-442, July-Aug. 2021. tab, graf
Artigo
em Inglês
| LILACS | ID: biblio-1339099
5.
Is there a role for peptide receptor radionuclide therapy in medullary thyroid cancer?
Clin Nucl Med
; 40(2): 123-7, 2015 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25546220